Professor Kefah MokbelFRCS is the lead consultant breast surgeon at the London Breast Institute of the Princess Grace Hospital, Professor of Breast Cancer Surgery at Brunel University London, UK, an honorary consultant breast surgeon at St. George's Hospital. Kefah Mokbel is the founder and current president of Breast Cancer Hope; a UK-based charity "dedicated to improving the quantity and quality of life in women diagnosed with breast cancer". He was appointed as a substantive consultant breast surgeon at St. George's Hospital NHS trust in February 2001. He was named in Tatler magazine's Best Doctors Guide as one of the featured "Top Breast Surgeons" in 2006, 2007 and 2013. In November 2010 he was named in the Times magazine's list of Britain's Top Doctors.
Personal details and education
Kefah Mokbel was born in 1965 in the currently occupied Golan Heights in Syria. At the end of junior high school, he was awarded a national scholarship after he passed the Brevet des collèges diploma with the highest score in Syria. In 1983 he was awarded a scholarship to study medicine in the United Kingdom having achieved 100% score in the Baccalaureate. Kefah Mokbel learned English in Eastbourne and then studied A levels in a boarding school in Shrewsbury and achieved 3 A grades and distinction in the special papers within one year. He graduated from the University of London in 1990. Kefah was a phenomenal self learner and was awarded several prestigious prizes during his undergraduate medical training and achieved the highest score in General Medicine at The London Hospital Medical College. He qualified as a Fellow of the Royal College of Surgeons in 1994. He was granted the Master of Surgery degree in 2000 by The Imperial College of Science, Technology and Medicine for his research in the field of molecular biology of breast cancer. In 2002, Mokbel was appointed an Honorary Professor at The Brunel Institute of Cancer Genetics and Pharmacogenomics at Brunel University in recognition of his contribution to breast cancer research. In 2005, he was appointed as a Reader in Breast Surgery at St. George's University of London in recognition of his outstanding research contribution in the field of breast cancer.
Clinical interests
Mokbel's clinical interests in the field of breast surgery include the early detection of breast cancer, breast ductoscopy, minimally-invasive breast surgery, sentinel node biopsy, skin-sparing mastectomy, breast reconstruction, cosmetic breast surgery, prevention of breast cancer, genetic predisposition, integrative oncology and the management of benign conditions including breast cysts, mastalgia and fibroadenomas. Mokbel has extensive experience in the field of reconstructive and aesthetic breast surgery including augmentation mammoplasty, reduction mammoplasty and mastopexy.
Research interests
Kefah Mokbel's main research interest lies in the field of molecular biology and the clinical management of breast cancer. Furthermore, he has published several papers in the field of aesthetic breast surgery including breast reconstruction following mastectomy and augmentation mammoplasty using implants and fat transfer. His prolific research output includes over 300 published papers in medical literature. According to Google Scholar Kefah Mokbel has 350 publications which have been cited more than 7000 times with a H-index of 50 and an i10-index of 167. Furthermore, his research linked the SET domain containing protein 2 gene to human breast cancer. He has also written 14 books in various disciplines including surgery, oncology, breast cancer, and postgraduate medical education. Mokbel is a member of the editorial board of several international medical journals... and a peer reviewer for leading medical journals including The Lancet. Mokbel has supervised and examined a significant number of higher postgraduate degrees in the field of breast cancer including PhD, MSc, MD and Master of Surgery degrees. In October 2017 Professor Mokbel and his team reported through a metaanalysis that the use of hair dyes could be associated with a 20% increase in breast cancer risk. In October 2018, Professor Mokbel and his team reported that the use of testosterone gel for hyposexual desire might not increase breast cancer risk among women using it.
Kefah Mokbel is currently the Director of Breast Surgery at The London Breast Institute of The Princess Grace Hospital, chair of the multidisciplinary breast cancer program of the London Breast Institute, Professor of Breast Cancer Surgery, Honorary Consultant Breast Surgeon at St. George's Hospital and President of Breast Cancer Hope Foundation. He is a member of the editorial board of several international medical journals and a member of the medical advisory committee at the Princess Grace Hospital. Furthermore, he is a member of the editorial boards of several international medical journals.
